↓ Skip to main content

Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer

Overview of attention for article published in Molecular Cancer, April 2005
Altmetric Badge

Mentioned by

wikipedia
1 Wikipedia page

Citations

dimensions_citation
81 Dimensions

Readers on

mendeley
27 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer
Published in
Molecular Cancer, April 2005
DOI 10.1186/1476-4598-4-14
Pubmed ID
Authors

Junsheng Li, Jörg Kleeff, Ivane Abiatari, Hany Kayed, Nathalia A Giese, Klaus Felix, Thomas Giese, Markus W Büchler, Helmut Friess

Abstract

Hsulf-1 is a newly identified enzyme, which has the ability to decrease the growth of hepatocellular, ovarian, and head and neck squamous cell carcinoma cells by interfering with heparin-binding growth factor signaling. Since pancreatic cancers over-express a number of heparin-binding growth factors and their receptors, the expression and function of this enzyme in pancreatic cancer was analyzed.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Ukraine 1 4%
Germany 1 4%
Australia 1 4%
Unknown 24 89%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 30%
Researcher 6 22%
Professor > Associate Professor 5 19%
Student > Bachelor 3 11%
Student > Doctoral Student 2 7%
Other 1 4%
Unknown 2 7%
Readers by discipline Count As %
Agricultural and Biological Sciences 10 37%
Biochemistry, Genetics and Molecular Biology 7 26%
Medicine and Dentistry 3 11%
Chemistry 2 7%
Social Sciences 1 4%
Other 1 4%
Unknown 3 11%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 January 2008.
All research outputs
#7,454,298
of 22,789,076 outputs
Outputs from Molecular Cancer
#547
of 1,719 outputs
Outputs of similar age
#20,766
of 59,614 outputs
Outputs of similar age from Molecular Cancer
#1
of 3 outputs
Altmetric has tracked 22,789,076 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,719 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 59,614 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them